On the other hand, small molecules inhibiting SARM1 promote the rescue of damaged axons that would otherwise degenerate (Hughes et al., 2021), and inhibiting SARM1 pharmacologically might protect axon organization and function in paclitaxel-induced peripheral neuropathy (Bosanac et al., 2021). This evidence concerns the gene SARM1 and peripheral neuropathy.